Estay R, Cortes A, Muller B, Tempio F, et al. Phase I trial of a heat-conditioned tumor lysate vaccine (TRIMELVax) in anti-PD-1 refractory melanoma: safety and immunological aspects (NCT06556004). Br J Cancer 2026 Apr 30. doi: 10.1038/s41416-026-03459.
PMID: 42062531